Cardiac management during adjuvant trastuzumab therapy: recommendations of the Canadian Trastuzumab Working Group

Trastuzumab has been shown to be an effective therapy for women with breast cancer that overexpresses the human epidermal growth factor receptor 2 (her2) protein. In the pivotal metastatic breast cancer trials, cardiac dysfunction was observed in women treated with trastuzumab and chemotherapy. The...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Mackey, J.R., Clemons, M., Côté, M.A., Delgado, D., Dent, S., Paterson, A., Provencher, L., Sawyer, M.B., Verma, S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Multimed Inc. 2008
Schlagworte:
Practice Guideline Series
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2259434/
https://ncbi.nlm.nih.gov/pubmed/18317582
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge